Meet the keynote speakers

GIM-barrangou.jpg

Rodolphe Barrangou

Field of expertise: 
CRISPR and applications in bacteria

Current position: 
Todd. R. Klaenhammer Distinguished Professor in Probiotic Research at North Carolina State University

Speaker bio:
The Barrangou lab focuses on the evolution and functions of CRISPR-Cas systems, and their applications in bacteria used in food manufacturing. For his work establishing the biological function of CRISPR, Rodolphe received the 2016 Warren Alpert Prize, the 2016 Canada Gairdner International Award, the 2017 NAS Award in Molecular Biology and the 2018 NAS Prize in Food and Agriculture Sciences, and was elected into the US National Academy of Sciences. Dr. Barrangou has also been involved with Caribou Biosciences Intellia Therapeutics, Locus Biosciences, and is the Editor in Chief of the CRISPR Journal.

Presentation title:
The CRISPR craze: from adaptive immunity to the genome editing revolution


GIM-bonfante.jpg

Paola Bonfante

Field of expertise:
Plant-Microbe interactions

Current position:
Professor, University of Torino

Speaker bio:
Paola’s research is focused on the biology of symbiotic associations, mainly mycorrhizas. She has studied the intimate interactions that occur between mycorrhizal fungi and plants, mostly focusing on cell plant re-organization upon AM fungal entry by using cellular and molecular approaches. Applying DNA technologies, early in the nineties, she provided contribution to the knowledge of mycorrhizal diversity in natural and agricultural environments. She has discovered a group of endobacteria which live inside mycorrhizal fungi and may modulate some of the functional traits of their fungal hosts. Her major current projects are focused on crop responses to soil microbiota and to the description of AM genomes.

Presentation title: To be confirmed

 

Read more about Paola Bonfante.

See Paola Bonfante's publication list.


GIM-ebright.jpg


Richard H. Ebright

Field of expertise: 
Structure and function of bacterial transcription ; development of small-molecule inhibitors of bacterial transcription as antituberculosis agents and broad-spectrum antibacterial agents

Current position: 
Board of Governors Professor of Chemistary and Chemical Biology, Rutgers University; Laboratory Director, Wasman Institute of Microbiology

Speaker bio:
Richard H. Ebright, Ph.D., is Board of Governors Professor of Chemistry and Chemical Biology at Rutgers University and Laboratory Director at the Waksman Institute of Microbiology.  His research focusses on the structure, mechanism, and regulation of bacterial transcription complexes, and on development of inhibitors of bacterial transcription as antibacterial drugs.  His research employs tools of structural biology, biophysics, and drug discovery.  He received his A.B. (summa cum laude) and Ph.D. degrees from Harvard University.  He performed graduate research at Harvard and the Institut Pasteur and was a Junior Fellow of the Harvard University Society of Fellows.  He has received the Searle Scholar Award, the Schering-Plough Award of the American Society for Biochemistry and Molecular Biology, and the Walter J. Johnson Prize.  He is a Member of the American Academy of Arts and Sciences and a Fellow of the American Association for Advancement of Science, the American Academy of Microbiology, and the Infectious Diseases Society of America.

Presentation title:
Small-molecule inhibitors of bacterial RNA polymerase: myxopyronins

Read more about Richard H. Ebright here.


gim-SUGA.jpg

Hiroaki Suga

Field of expertise: 
In vitro synthetic biology

Current position: 
Professor

Speaker bio:
Professor Hiroaki Suga received his Ph. D. in Chemistry (1994) at MIT, USA. He was appointed in the Department of Chemistry, SUNY at Buffalo as Assistant/Associate Professor (1997-2002). In 2004, he moved to the Research Center and since 2010 has been in the Department of Chemistry, Graduate School of Science in the University of Tokyo. He is the recipient of Akabori Memorial Award 2014, Japanese Peptide Society, Max-Bergmann Gold Medal 2016, Nagoya Medal 2017 Silver, etc. He is also a founder of PeptiDream Inc. Tokyo, a publicly traded company in the first stock Tokyo exchange market, which has many partnerships with pharmaceutical companies in worldwide.

Presentation title:
In vitro pseudo-natural product biosynthesis and selection 

Read more about Hiroaki Suga here.